Supply Chain Operations and Compliance in Pharma 2017

Being able to deliver quality drug products to patients on-time is the top priority of bio-pharma. A seamless and compliant supply chain operation is therefore of utmost importance to drug developers. However, the pharma supply chain has become more complex and globalized over the last few years. The rise of virtual biotechs and supply networks, and the number of 3PLs involved, have made maintaining a round-the-clock operation a real challenge. Coupled with this, a recent report from McKinsey suggested pharma manufacturers could save $25 billion on supply chain inefficiencies*.